20th Aug 2025 10:32
ConvaTec Group PLC - London-based medical products - Starts on Wednesday a share buyback worth up to USD300 million. The buyback will be run by UBS AG and will be completed by the end of December, though ConvaTec says it could be extended. Some repurchased shares will be held in Treasury for employee share plans, with the rest cancelled. ConvaTec says the buyback is being launched after it confirmed its 2025 guidance in its half-year results last month.
Current stock price: 244.40 pence, up 5.7% in London on Wednesday
12-month change: up 4.4%
By Tom Waite, Alliance News editor
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Related Shares:
ConvaTec